Sunday, March 14, 2010

prenatal diagnosis of congenital mesoblastic nephroma--a case report by Dr. Nayan.

Prenatal diagnosis of Mesoblastic Nephroma associated with polyhydramnios: a case report .

Dr Nayan Sarkar MD, DNB (India).Obstetrician and Gynaecoligist.

Lhaviyani Atoll Hospital, Naifaru, Republic Of Maldives.

E-mail: drnayan_sarkar@yahoo.com


Introduction

Fetal kidney tumour is an extremely rare phenomenon in clinical practice and diagnosis of it antenataly is exceptional. The echographic feature of the surrounding structures makes it difficult to image both kidneys satisfactorily. Most of the kidney diseases are cystic and obstructive type of nephropathy associated with oligohydramnios[1].Only few cases diagnosed by prenatal ultrasound have been reported so far in world literature .This present case report elucidates sonographic features of a Mesoblastic Nephroma with polyhydramnios at term in labour and formulates a brief discussion.

Case report

A 20-years-old primigravida presented to our Emergency Obstetrics Services at term with concerns of suspected rupture of membranes and leaking of amniotic fluid in early labour. As there was no obvious leakage of fluid, an emergency ultrasound was performed and severe polyhydramnios was visualized which guided to perform a detailed ultrasound examination. A detailed appraisal revealed an abdominal circumference significantly greater than other biometric measurements.BPD, HC, FL were concurring to 34 weeks of gestation whereas abdominal circumference showed 38 weeks. Presence of an intraabdominal solid tumour with well defined borders that displaced the foetal liver cranially was noted. The size of the tumour was 7.5×6.9 cms. The normal appearing left kidney was noted but the right kidney could not be identified. It was a male foetus with normal appearing bladder and urethral region. Based on these findings of solid renal mass and associated polyhydramnios a Congenital Mesoblastic Nephroma was proposed as possible diagnosis. There was no history of maternal diabetes. It was a non consanguineous marriage. As patient went into active labour and could not tolerate pain a caesarean section was performed at maternal request. Neonate was born with a good Apgar score and examination revealed a huge solid mass occupying almost the whole right side of abdomen. Baby had neonatal problem of transient respiratory difficulty and jaundice which got settled .CT scan abdomen revealed a neoplastic lesion arising from mid and lower third of right kidney and extending abdominal quadrants. No vascular invasion was noted and a diagnosis of Mesoblastic Nephroma was suggested. The neonate was operated in India two weeks after birth .A right sided nephrouretrectomy was done .Right kidney was totally replaced by a solid tumour of 7.5×6.9 cms, with round and well defined borders, the cut surface was yello-grey,firm, rubbery in consistency. His postoperative period was complicated by mild feed intolerance and suspected sepsis which was managed by iv antibiotics. Histopathology confirmed the diagnosis of Mesoblastic Nephroma. Microscopy revealed interlaced bundles of fibroblast and myofibroblast with eosinophilic and fibrillar cytoplasm and round to oval nuclei. There were focal areas of immature cartilage and dysplastic glomeruli and tubules.

Sonography:

Polyhydramnios –the first clinical clue of many congenital anomalies, though most renal anomalies are associated with oligohydramnios.

Solid mass of 6.9×7.5 cms. in abdomino-pelvic area

Foetal biometry- both BPD & FL show gestational age of around 33-34 weeks.


Disproportionately advanced gestational age of 38 weeks by abdominal circumference because of intra-abdominal mass.

Discussion

When a unilateral renal tumour is diagnosed by prenatal ultrasound associated with polyhydramnios we have to believe it to be a case of Congenital Mesoblastic Nephroma vs. Wilm’s tumour. Very few cases of Mesoblastic Nephroma have been reported and all were unilateral and diameters between 0.8 and 14 cm[2] associated with polyhydramnios. Though Wilm`s tumour have been observed neonatally its prenatal detection is almost unknown [3].Mesoblastic Nephroma on prenatal ultrasound usually appears as an unilateral solid paravertebral mass with a low-level, non-homogenous echo pattern. Although some areas with high echo and small echo free areas representing intratumour haemorrhage and necrosis may occur [4]. Disproportionately increased dimension of foetal trunk depending upon the size of the tumour provides an important clue [5]. A well defined border of the tumour represents the line between the lesion and the adjacent tissue. Mesoblastic Nephroma can partially show lobation with linear demarcations indenting the surface and interlobar grooves as described on normal kidneys. [6]. The tumour can also show an indistinct border.[7]. Polyhydramnios is an indicative point in diagnosis since other renal mass usually are associated with oligohydramnios.Increased renal blood flow and impaired renal concentrating ability may be reasons for foetal polyuria and polyhydramnios[8].Displacement and compression of the GI tract by the solid tumour may impair amniotic fluid absorption and eventually lead to the development of polyhydramnios.To differentiate a Mesoblastic Nephroma from Wilm’s tumour we need histopathology, but it is true that Mesoblastic Nephroma have been diagnosed more frequently in utero.In infantile polycystic kidney disease there will be bilateral renal enlargement and oligohydramnios with non visualization of foetal bladder. In diffuse nephromatosis [9] both kidneys are involved and may show acoustic shadowing due to calcification. Kidney enlargement in some inherited disorders such as Meckels syndrome is generally bilateral. Solid tumour arising in paravertebral area from adrenal gland or extrathorasic pulmonary sequestration can be distinguished from renal tumour by the presence of a normal appearing kidney in that area. Severe polyhydramnios may necessitate periodic amniocentesis to prevent preterm labour for polyhydramnios. Antenatal steroid should be given thinking that polyhydramnios may lead to prelabour rupture of membrane and preterm labour and delivery. If diagnosed early a serial ultrasound to evaluate tumour growth and foetal growth should be performed and a thorough search for other associated anomalies as well. Isolated congenital Mesoblastic Nephroma carries an excellent prognosis after neonatal surgery is performed, and hence ruling out of any other anomalies is so important. Unless dystocia because of huge foetal abdomen is anticipated caesarean delivery per se is not a requirement. Although it is desirable to arrange delivery of such a case in an equipped hospital with facility to do paediatric surgery situation may arise as we had to deliver her by caesarean and then refer to abroad. Even though most patient will be cured and do excellent after nephroureterectomy[10] periodic follow up should be scheduled and followed as our case is following.

References:

1. Callan NA, Blakemore K, Park J, et al: Fetal genitourinary tract anomalies: Evaluation, operative correction, and follow-up. Obstet Gynecol 75:67-74, 1990.

2. Yambao TJ, Schwartz D, Henderson, et al: Prenatal deagnosis of congenital Mesoblastic Nephroma. A case report. J Reprod Med 31:257-259, 1986.

3. Seeds AE: Current concepts of amniotic fluid dynamics. Am J Obstet Gynecol 138:575-586,

4. Ganick DJ, Gilbert EF, Beckwith JB, Kfiviat N. Congenital cystic Mesoblastic Nephroma. Hum Pathol 1981;12L1039.

5. Walter JP. McGahan JP: Mesoblastic Nephroma: Prenatal sonographic detection. JCU 13:686-689, 1985.

6. Slasky BS, Penkrot RJ, Bron KM: Cystic Mesoblastic Nephroma. Urology19:220-223, 1982.

7. Geirsson RT, Ricketts NEM, Taylor DJ, Coghill S: Prenatal appearance of a Mesoblastic Nephroma associated with polyhydramnios JCU 13:488-490, 1985.

8. Kuo CY, Tsau YK, Yau KI, et al: Congenital Mesoblastic Nephroma: report of a case. Taiwan I Hsueh Hui Tsa Chih 88:836-838, 1989.

9. Jaffe MH, White SJ, Siver TM: Wilms tumor: Ultrasonic features, pathologic correlation, and diagnostic pitfalls. Radiology 140:147-152,1981.

10. Howell CG, Othersen HB, Kiviat NE, et al: Therapy and outcome in 51 children with Mesoblastic Nephroma: A report of the national Wilms tumor study. J Pediatr Surg 17:826-831,1982.

Thursday, March 11, 2010

Sneha's recent photos


These are Sneha's recent photos

Tuesday, October 27, 2009

Friday, July 17, 2009

pharmacology of contraception

contraception pharmacology
Pharmacology of contraception (female, hormonal)

Contraception = reversible control of fertility to prevent pregnancy, STIs
The ideal contraception (doesn’t exist):
Fully reversible
100% effective
Convenient and easy to use – maintenance-free
Free of adverse side effects
Cheap
Prevents STI transmission

Types of female hormonal contraception
The pill (combined estrogen and progesterone oral contraceptive pill)
Mini pill (low dose progesterone pill)
Depo-Provera (progesterone injection)
Progesterone implant (implanon)
Intra-uterine device
Nuva ring
Emergency contraception


Estrogens (umbrella term)
Naturally occurring
Estradiol ß most biological activity + main ovary hormone secretion
Estriol – placental estrogen (high during pregnancy)
Estrone – main estrogen in menopausal women ß from androgens
Synthetic (in COCP)
Ethynyl estradiol (EE) – most common
Mestranol (converts to EE)
Effect: growth, ovulation, +endometrium, vaginal cornification (keratin)

Progestogen (umbrella term)
Progesterone (natural)
If taken orally à progesterone metabolised à ineffective à for contraception, progestin ingested and converted to progesterone
Progestin (synthetic)
Wide range of activity (eg. able to bind to oestrogen, progesterone, testosterone and cortisteroid receptors) à complex array of effects
Heaps of types, mainly: derivatives of 19 nor-testosterone and derivatives of levonorgestrel

1: The combined oral contraceptive pill (COCP)
7 green sugar pills simulate period à withdrawal bleeding occurs + gives body break from steroid hormones
Don’t have to take – but there so that user can get used to taking pills ever day
21 pink hormonal pills

A: How it works
Different pills differ in amount of estrogen and type of progestin
Originally 100 μg estrogen dose
Now 20-50 μg estrogen dose with progestin
Start taking on 1st day of natural cycle
Estrogen
Prevents ovulation ß negative feedback suppress estrogen peak
Progesterone
Hostile cervical mucus (more difficult for sperm to penetrate)
Hostile endometrium (more difficult for conceptus to implant)
Normally progesterone aids implantation, but here, progesterone is continuous leading to atrophic endometrium

B: Preparations
Early pills had monophasic preparation: amount of estrogen = progesterone
Biphasic prep and triphasic prep: various amounts of active ingredients
Approximately mimics hormonal cycles
Reduce overall amounts of steroids

C: Effectiveness
However, fairly forgiving; if you miss pill:
Take within 12 hours
Or double next dose
If missed for 2 days – continue, but this cycle and next assume lack of protection0.2-3% failure (mostly due to poor compliance)
Theoretical effectiveness 99.9%
User effectiveness 97-98%

D: Reasons for failure
Poor compliance
Most dangerous to miss pills either side of the sugar pills – increase window for recovery of anterior pituitary (FSH, LH had been previously suppressed by negative feedback)
Poor absorption (metabolised; vomiting or diarrhoea within 2 hours)
Interference from other drugs
Broad-spectrum antibiotics affect normal bowel flora à affects enterohepatic circulation of estrogen à so estrogen is secreted but not reabsorbed à blood levels fall à negative feedback inhibited

E: Reversibility
Median of 3 months before conception
Possible post-pill amenorrhea (absence of menstrual period in a woman of reproductive age), but does not cause infertility

F: Side-effects – most are dose-dependent (hence lower dose if experienced)
Some pills induce liver metabolism of estrogens à have to switch to pills with a higher estrogen concentration or a non-estrogen pill
DVT and pulmonary embolism
Due to E&P screwing around with factors that affect blood clotting
Hypertension (more likely in old, heavier women + with family history)
Myocardial infarction + coronary artery disease
Women over 35 who smoke à 8-fold risk; dose related
Stroke
Due to E&P screwing around with factors that affect blood clotting
Increased risk only for smokers + those with other risks for stroke
Hepatic effects in predisposed women; rare
Increased risk of breast cancer
Decreased risk of ovarian and endometrial cancer
Progestin counters estrogen proliferation
Mild nausea, flushing, dizziness, sore breasts
Mood changes
Diabetic effect – abnormal glucose
Acne, hirsutism ß androgenic effects

G: Relative contraindications
Migraines (especially with aura), hypertension, diabetes mellitus, gallbladder disease, obstructive jaundice of pregnancy

H: Absolute contraindications
History of thromboembolic disease
Cerebral vascular disease, myocardial infarction, coronary artery disease
Congenital hyperlipidaemia
Suspected cancer of reproductive tract (eg. abnormal vaginal bleeding), breast, or of other hormone-dependent or hormone-responsive neoplasia
Poor liver; history of liver tumour
Pregnancy, breast-feeding
Women over 35 who smoke >15 ciggies a day

2: Mini-pill

A: How it works
Progestin only and in a lower dose
Hostile cervical mucus
Hostile endometrium
Suppresses ovulation in about 2/3 of women
No hormone-free week (progesterone levels easily slip below)

B: Market
Breast-feeding (estrogen inhibits lactation)
Also, prolactin (not very effectively) inhibits pregnancy – but combined with mini-pill quite effective, though not as effective as COCP
Estrogen intolerance
Progesterone intolerance when in high doses

C: Effectiveness
Theoretical: 99%; user effectiveness: 96-97.5%

D: Reasons for failure
Late, missed pills ß mini-pill not forgiving like COCP; same time, every day
Poor absorption of pill
However, unlike COCP, not influenced / interfered by other

E: Side effects
Irregular, unpredictable spotting (bleeding) and breakthrough bleeding

F: Contraindications
Undiagnosed vaginal bleeding
Benign or malignant liver disease
Breast cancer

3: Depo-Provera (DMPA - depot medroxyprogesterone acetate)

A: How it works
· Intramuscular medroxyprogesterone acetate injection every 3 months
o Converts to progesterone
· Ovulation suppression, hostile cervical mucus, hostile endometrium
B: Market
· Estrogen intolerance / breast-feeding
· Poor compliance
C: Effectiveness - 99%
D: Reasons for failure - late injections
E: Side effects – breakthrough bleeding; infertility may persist for many months
4: Progesterone implant (implanon)

A: How it works
· Rod, about half a matchstick in size, inserted into inner arm
· Slow, continuous release of progestin for 5 years
· Ovulation suppression, hostile cervical mucus, hostile endometrium
B: Effectiveness – 0-0.1% failure à most effective hormonal contraception
C: Reasons for failure – insertion error

5: Intra-uterine device (IUD) (mirena) – most widely used (worldwide)

A: How it works
· Progestins: local release à hostile cervical mucus, hostile endometrium
· Physical presence + spermicide à inhibits sperm movement and function
· Slow release over 5-10 years (new versions longer)
B: Market
· Women with complete families
· Intolerance to systemic progesterone or progesterone
C: Effectiveness - 0.1% failure rate
D: Reasons for failure – IUD expelled from uterus; rare

6: Nuva Ring
Small flexible vaginal ring à new ring inserted at beginning of each cycle
Removed for 7 days after 21 days for withdrawal bleeding
Progesterone + estrogen à absorbed through vaginal mucosa
Fewer side effects than COCP
More practical effectiveness than COCP due to reduced need for compliance

7: Emergency contraception

A: How it works
· Currently: 2 huge doses of levonorgestrel (type of progestin) either 12 hours apart or as a single double dose
o Effective even if 5 days after
· Hostile endometrium & cervical mucus, delays/prevents ovulation
· Interferes with function of corpus luteum
· Alterations in tubular transport of sperm, ovum and embryo
B: Effectiveness – 60-70% effective in preventing a pregnancy that would have otherwise occurred